Carol Schafer
Director/Board Member bei REPARE THERAPEUTICS INC.
Vermögen: 505 944 $ am 31.03.2024
Profil
Carol Anne Schafer's current jobs include being an Independent Director at Insmed, Inc. since 2020, an Independent Director at Immunome, Inc. since 2024, an Independent Director at Kura Oncology, Inc. since 2021, an Independent Director at Repare Therapeutics, Inc. since 2019, a Director at Onegoal New York since 2019, and a Managing Partner at Hyphen Advisors LLC since 2018.
Her former jobs include being the Vice Chairman-Equity Capital Markets at Wells Fargo Securities LLC from 2007 to 2018, an Independent Director at Idera Pharmaceuticals, Inc. from 2018 to 2022, an Independent Director at Five Prime Therapeutics, Inc. from 2019 to 2021, the VP-Finance, Business Development & Communications at Lexicon Pharmaceuticals, Inc. from 2003 to 2007, and an MD, VP & Head-Equity Capital Markets at J.P.
Morgan & Co., Inc. (Old) from 1986 to 2003.
Ms. Schafer's education includes an undergraduate degree from Boston College and an MBA from The Leonard N Stern School of Business.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
INSMED INCORPORATED
0,01% | 11.05.2023 | 17 260 ( 0,01% ) | 468 264 $ | 31.03.2024 |
REPARE THERAPEUTICS INC.
0,02% | 08.06.2023 | 8 000 ( 0,02% ) | 37 680 $ | 31.03.2024 |
IMMUNOME, INC.
-.--% | 02.01.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
KURA ONCOLOGY, INC.
-.--% | 31.03.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Carol Schafer
Unternehmen | Position | Beginn |
---|---|---|
REPARE THERAPEUTICS INC. | Director/Board Member | 01.03.2019 |
INSMED INCORPORATED | Director/Board Member | 01.04.2020 |
KURA ONCOLOGY, INC. | Director/Board Member | 03.06.2021 |
IMMUNOME, INC. | Director/Board Member | 02.01.2024 |
Hyphen Advisors LLC | Chief Executive Officer | 01.01.2018 |
Onegoal New York
Onegoal New York Miscellaneous Commercial ServicesCommercial Services Onegoal New York operates a social services organization. The private company is based in New York. | Director/Board Member | 01.03.2019 |
Ehemalige bekannte Positionen von Carol Schafer
Unternehmen | Position | Ende |
---|---|---|
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Director/Board Member | 28.09.2022 |
FIVE PRIME THERAPEUTICS, INC. | Director/Board Member | 16.04.2021 |
Wells Fargo Securities LLC
Wells Fargo Securities LLC Investment Banks/BrokersFinance Wells Fargo Securities LLC (WFS) is the broker/dealer subsidiary of EVEREN Capital Corp., ultimately owned by Wells Fargo & Co. (NYSE: WFC). Headquartered in New York, WFS delivers a comprehensive suite of banking, capital markets and advisory solutions, such as a full complement of sales, trading and research capabilities, to corporate, government and institutional clients. | Corporate Officer/Principal | 01.09.2018 |
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░░░ ░░░░░ ░░░░ ░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Carol Schafer
Boston College | Undergraduate Degree |
The Leonard N Stern School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 5 |
---|---|
LEXICON PHARMACEUTICALS, INC. | Health Technology |
INSMED INCORPORATED | Health Technology |
IMMUNOME, INC. | Health Technology |
KURA ONCOLOGY, INC. | Health Technology |
REPARE THERAPEUTICS INC. | Health Technology |
Private Unternehmen | 6 |
---|---|
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Health Technology |
Five Prime Therapeutics, Inc.
Five Prime Therapeutics, Inc. BiotechnologyHealth Technology Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of novel protein therapeutics. Its product candidates includes, Cabiralizumab (FPA008), Bemarituzumab (FPA144), and FPA150. The FPA008 is an antibody that inhibits colony stimulating factor-1, or CSF1, receptor, or CSF1R, that are developing in rheumatoid arthritis and plan to clinically develop in pigmented villonodular synovitis, or PVNS, and in combination with nivolumab in multiple cancers. The FPA144 is an antibody that inhibits fibroblast growth factor receptor 2b, or FGFR2b, that are developing to treat patients with gastric cancer. The FPA150 is a CD8 T cell checkpoint which targets B7-H4 that is developing as a monotherapy in multiple cancers. The company was founded by Lewis T. Williams in December 2001 and is headquartered in South San Francisco, C. | Health Technology |
J.P. Morgan & Co., Inc. (Old) | Finance |
Wells Fargo Securities LLC
Wells Fargo Securities LLC Investment Banks/BrokersFinance Wells Fargo Securities LLC (WFS) is the broker/dealer subsidiary of EVEREN Capital Corp., ultimately owned by Wells Fargo & Co. (NYSE: WFC). Headquartered in New York, WFS delivers a comprehensive suite of banking, capital markets and advisory solutions, such as a full complement of sales, trading and research capabilities, to corporate, government and institutional clients. | Finance |
Onegoal New York
Onegoal New York Miscellaneous Commercial ServicesCommercial Services Onegoal New York operates a social services organization. The private company is based in New York. | Commercial Services |
Hyphen Advisors LLC |